Endurant Capital Management LP Dynavax Technologies Corp Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$3.65 - $7.89 $150,701 - $325,762
-41,288 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$7.08 - $12.09 $292,319 - $499,171
41,288 New
41,288 $302,000
Q4 2017

Feb 14, 2018
SELL
$17.3 - $24.08 $873,650 - $1.22 Million
-50,500 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$15.2 - $21.5 $767,600 - $1.09 Million
50,500
50,500 $1.09 Million

Others Institutions Holding DVAX

# of Institutions
269
Shares Held
132M
Call Options Held
326K
Put Options Held
758K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.42B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email